Retraction notice to “Dopamine Ds3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors” [Pharmacology, Biochemistry and Behavior 171 (2018) 46–53](S0091305718300236)(10.1016/j.pbb.2018.05.015)

Gregory L. Powell, John Paul Bonadonna, Annika Vannan, Kuiying Xu, Robert H. Mach, Robert T. Luedtke, Janet L. Neisewander

Research output: Contribution to journalComment/debate

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). The approved IACUC protocol used in the experiment described in this manuscript states that the dose of cocaine administered ranges up to 10 mg/kg, IP, but in this study the authors used 15 mg/kg, IP (Box 6)

Original languageEnglish
Number of pages1
JournalPharmacology Biochemistry and Behavior
Volume176
DOIs
StatePublished - 1 Jan 2019

Fingerprint

Biochemistry
Dopamine Receptors
Cocaine
Animal Care Committees
Pharmacology
Industry
Experiments
N-((4-(4-(2-(2-fluoroethoxy)phenyl)-1-piperazinyl)butyl)-4-(3-thienyl)benzamide

Cite this

@article{5ef343d7d92d499f84010328b93554af,
title = "Retraction notice to “Dopamine Ds3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors” [Pharmacology, Biochemistry and Behavior 171 (2018) 46–53](S0091305718300236)(10.1016/j.pbb.2018.05.015)",
abstract = "This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). The approved IACUC protocol used in the experiment described in this manuscript states that the dose of cocaine administered ranges up to 10 mg/kg, IP, but in this study the authors used 15 mg/kg, IP (Box 6)",
author = "Powell, {Gregory L.} and Bonadonna, {John Paul} and Annika Vannan and Kuiying Xu and Mach, {Robert H.} and Luedtke, {Robert T.} and Neisewander, {Janet L.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.pbb.2018.12.011",
language = "English",
volume = "176",
journal = "Pharmacology, Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",

}

Retraction notice to “Dopamine Ds3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors” [Pharmacology, Biochemistry and Behavior 171 (2018) 46–53](S0091305718300236)(10.1016/j.pbb.2018.05.015). / Powell, Gregory L.; Bonadonna, John Paul; Vannan, Annika; Xu, Kuiying; Mach, Robert H.; Luedtke, Robert T.; Neisewander, Janet L.

In: Pharmacology Biochemistry and Behavior, Vol. 176, 01.01.2019.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - Retraction notice to “Dopamine Ds3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors” [Pharmacology, Biochemistry and Behavior 171 (2018) 46–53](S0091305718300236)(10.1016/j.pbb.2018.05.015)

AU - Powell, Gregory L.

AU - Bonadonna, John Paul

AU - Vannan, Annika

AU - Xu, Kuiying

AU - Mach, Robert H.

AU - Luedtke, Robert T.

AU - Neisewander, Janet L.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). The approved IACUC protocol used in the experiment described in this manuscript states that the dose of cocaine administered ranges up to 10 mg/kg, IP, but in this study the authors used 15 mg/kg, IP (Box 6)

AB - This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). The approved IACUC protocol used in the experiment described in this manuscript states that the dose of cocaine administered ranges up to 10 mg/kg, IP, but in this study the authors used 15 mg/kg, IP (Box 6)

UR - http://www.scopus.com/inward/record.url?scp=85059443653&partnerID=8YFLogxK

U2 - 10.1016/j.pbb.2018.12.011

DO - 10.1016/j.pbb.2018.12.011

M3 - Comment/debate

C2 - 30616777

AN - SCOPUS:85059443653

VL - 176

JO - Pharmacology, Biochemistry and Behavior

JF - Pharmacology, Biochemistry and Behavior

SN - 0091-3057

ER -